{"id":"W4392603265","doi":"10.1093/arclin/acae014","title":"<i>BDNF</i> Val66Met moderates episodic memory decline and tau biomarker increases in early sporadic Alzheimer’s disease","year":2024,"lang":"en","type":"article","venue":"Archives of Clinical Neuropsychology","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute on Aging; National Health and Medical Research Council; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Institutes of Health; Genentech; Takeda Pharmaceutical Company; IXICO; H. Lundbeck A/S; Servier; Eisai; Northern California Institute for Research and Education; Pfizer; Biogen; BioClinica; University of Southern California; Eli Lilly and Company; U.S. Department of Defense; Meso Scale Diagnostics; Alzheimer's Disease Neuroimaging Initiative; F. Hoffmann-La Roche; Australian Government; Novartis Pharmaceuticals Corporation; Bristol-Myers Squibb; Alzheimer's Drug Discovery Foundation; Alzheimer's Association","keywords":"Episodic memory; Cognitive decline; Dementia; Internal medicine; Psychology; Alzheimer's disease; Oncology; Brain-derived neurotrophic factor; Neurotrophic factors; Medicine; Disease; Cognition; Neuroscience; Receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005855935,0.0002148626,0.0004514922,0.0002820704,0.00006596928,0.00004624976,0.0003117796,0.00008993849,0.00003379672],"category_scores_gemma":[0.001498599,0.0001762684,0.0001917579,0.0003253465,0.001249539,0.0001926189,0.0001885795,0.0004175476,0.00002845186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001699485,"about_ca_system_score_gemma":0.00008607043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004257834,"about_ca_topic_score_gemma":0.00001277057,"domain_scores_codex":[0.9961519,0.001388662,0.001029928,0.0009234423,0.0002062701,0.000299766],"domain_scores_gemma":[0.9947096,0.004448985,0.0001466978,0.0004027989,0.00001446261,0.000277441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004715357,0.002413951,0.2245085,0.0001464842,0.00008197352,0.002341572,0.0002376656,0.0001490029,0.442344,0.01158663,0.001278506,0.3101964],"study_design_scores_gemma":[0.001216573,0.0006424483,0.9550283,0.00009882982,0.00008608009,0.00007583048,0.000004156405,0.008908336,0.01240369,0.02022429,0.001047156,0.0002643246],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928517,0.001538974,0.0001659993,0.002604273,0.0007530088,0.0002604245,0.00006196548,0.00008079044,0.00168287],"genre_scores_gemma":[0.9955775,0.001588855,0.0002316379,0.002230485,0.0001855554,0.00001646694,0.000008941322,0.00003416986,0.0001263801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7305198,"threshold_uncertainty_score":0.7188015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09505665304146647,"score_gpt":0.397594853304774,"score_spread":0.3025382002633075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}